BR112018011414A2 - método para produzir derivados de ácido n-retinoilaminoalcano sulfônico - Google Patents

método para produzir derivados de ácido n-retinoilaminoalcano sulfônico

Info

Publication number
BR112018011414A2
BR112018011414A2 BR112018011414A BR112018011414A BR112018011414A2 BR 112018011414 A2 BR112018011414 A2 BR 112018011414A2 BR 112018011414 A BR112018011414 A BR 112018011414A BR 112018011414 A BR112018011414 A BR 112018011414A BR 112018011414 A2 BR112018011414 A2 BR 112018011414A2
Authority
BR
Brazil
Prior art keywords
acid
sulfonic acid
producing
liquid phase
alkyl ester
Prior art date
Application number
BR112018011414A
Other languages
English (en)
Other versions
BR112018011414B1 (pt
Inventor
Babrou Dzianis
Aleksov Julian
Budnikava Maryna
Björklund Mikael
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Publication of BR112018011414A2 publication Critical patent/BR112018011414A2/pt
Publication of BR112018011414B1 publication Critical patent/BR112018011414B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/22Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/32Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

trata-se de um método para produzir derivados de ácido nretinoilaminoalcano sulfônico, sendo que o método compreende fornecer ácido retinoico, cloroformato, ácido aminoalcanossulfônico selecionado a partir do grupo que consiste em ácido cisteico e éster alquílico do mesmo, ácido cisteína sulfínico e éster alquílico do mesmo, ácido homocisteico e éster alquílico do mesmo, ácido homocisteína sulfínico e ésteres alquílicos do mesmo, taurina e derivados dos mesmos, e um solvente orgânico, e uma base, misturar os ditos componentes sob ausência substancial de compostos de oxidação formando, desse modo, uma mistura de reação que compreende uma fase líquida, em que a fase líquida é uma fase e os derivados de ácido n-retinoilaminoalcano sulfônico são formados na dita fase líquida.
BR112018011414-6A 2015-12-09 2016-12-09 Método para produzir derivados de ácido n-retinoilaminoalcano sulfônico BR112018011414B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1551615-6 2015-12-09
SE1551615 2015-12-09
PCT/SE2016/051238 WO2017099662A1 (en) 2015-12-09 2016-12-09 Method for producing n-retinoylcysteic acid alkyl ester

Publications (2)

Publication Number Publication Date
BR112018011414A2 true BR112018011414A2 (pt) 2018-11-27
BR112018011414B1 BR112018011414B1 (pt) 2022-09-20

Family

ID=59013796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018011414-6A BR112018011414B1 (pt) 2015-12-09 2016-12-09 Método para produzir derivados de ácido n-retinoilaminoalcano sulfônico

Country Status (21)

Country Link
US (2) US10138204B2 (pt)
EP (1) EP3386947B1 (pt)
JP (1) JP7009012B2 (pt)
KR (1) KR20180091851A (pt)
CN (2) CN116444463A (pt)
AU (1) AU2016365535B2 (pt)
BR (1) BR112018011414B1 (pt)
CA (1) CA3007624C (pt)
DK (1) DK3386947T3 (pt)
EA (1) EA037846B1 (pt)
ES (1) ES2881882T3 (pt)
HK (1) HK1258219A1 (pt)
LT (1) LT3386947T (pt)
MX (1) MX2018006894A (pt)
MY (1) MY184709A (pt)
NZ (1) NZ743639A (pt)
SG (1) SG11201804826TA (pt)
SI (1) SI3386947T1 (pt)
UA (1) UA124338C2 (pt)
WO (1) WO2017099662A1 (pt)
ZA (1) ZA201804250B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110218168B (zh) * 2018-03-02 2022-09-20 上海现代药物制剂工程研究中心有限公司 一种n-(全反式-视黄酰基)-l-半胱磺酸甲酯的钠盐的制备方法
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
US11072575B1 (en) * 2020-09-19 2021-07-27 Xi'an Taikomed Pharmaceutical Technology Co., Ltd. Method of preparing a cinnamyl alcohol retinoic acid ester with antioxidant and antibacterial activities
US11401239B1 (en) 2020-10-13 2022-08-02 Fxi Inc. Limited Process for converting disulfides to conversion products and process for producing cysteic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3002545A1 (de) * 1980-01-25 1981-07-30 Basf Ag, 6700 Ludwigshafen 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
EP1534672B1 (en) * 2002-07-23 2013-05-01 Ardenia Investments Ltd. Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
US7321064B1 (en) * 2007-03-08 2008-01-22 Cedarburg Pharmaceuticals, Inc. Preparation of amides of retinoic acid via mixed anhydride and mixed carbonate intermediates

Also Published As

Publication number Publication date
ZA201804250B (en) 2019-04-24
BR112018011414B1 (pt) 2022-09-20
CN116444463A (zh) 2023-07-18
UA124338C2 (uk) 2021-09-01
JP2019504005A (ja) 2019-02-14
LT3386947T (lt) 2021-09-10
ES2881882T3 (es) 2021-11-30
US20190127322A1 (en) 2019-05-02
MY184709A (en) 2021-04-19
HK1258219A1 (zh) 2019-11-08
SG11201804826TA (en) 2018-07-30
EP3386947A4 (en) 2019-05-15
NZ743639A (en) 2022-07-01
SI3386947T1 (sl) 2021-11-30
AU2016365535A1 (en) 2018-07-12
CN108473421A (zh) 2018-08-31
CA3007624C (en) 2024-04-09
KR20180091851A (ko) 2018-08-16
CA3007624A1 (en) 2017-06-15
DK3386947T3 (da) 2021-08-09
MX2018006894A (es) 2018-11-09
US10138204B2 (en) 2018-11-27
EP3386947B1 (en) 2021-05-19
WO2017099662A1 (en) 2017-06-15
US10322996B2 (en) 2019-06-18
JP7009012B2 (ja) 2022-01-25
AU2016365535B2 (en) 2020-07-23
US20180290973A1 (en) 2018-10-11
EP3386947A1 (en) 2018-10-17
EA037846B1 (ru) 2021-05-27
EA201891259A1 (ru) 2019-01-31

Similar Documents

Publication Publication Date Title
BR112018011414A2 (pt) método para produzir derivados de ácido n-retinoilaminoalcano sulfônico
BR112017018702A2 (pt) processo para preparar mesotriona
BR112012029213A2 (pt) processo para separar furfural a partir de uma fase aquosa líquida, e, uso de um composto de hidrocarboneto aromático
BR112012020596A8 (pt) substrato para a imobilização de substâncias funcionais e processo para preparar o mesmo.
BR112019009038A2 (pt) processo p para a cetonização descarboxilativa de ácidos graxos, método m para a preparação de pelo menos um composto final de pelo menos uma cetona interna, e, uso de um intermediário de cetona interna.
BR112017023522A2 (pt) processo para a cetonização descarboxilativa de ácidos graxos, derivados de ácido graxo ou misturas dos mesmos
BR112018067759A2 (pt) métodos para produzir um látex de polímero, para produzir uma composição de látex, para produzir um artigo moldado por imersão e para produzir um substrato de formação de camada adesiva.
BR112015017606A2 (pt) composição, método de produzir a composição, utilização da composição e combustível obtido a partir da composição
BR112013015688A2 (pt) processo para produção de furfural
BR112015030558A2 (pt) processo de descarbonatação de um gás hidrocarbonado
BR112014027663A2 (pt) processo para a oligomerização de um hidrocarboneto
PE20191649A1 (es) Proceso de separacion de multiples etapas
EA201691102A1 (ru) Способ удаления soиз газа при помощи полиольного сложного раствора
BR112016018069A2 (pt) Composições de surfactante aquoso
CL2012001648A1 (es) Composicion saborizante de maillard que comprende una fase lipidica estructurada donde el solvente o mezcla de solvente polar no es agua, al menos un producto de reaccion de maillard; proceso de elaboracio que comprende hacer una fase lipidica estructurada de una fase lipidica continua de un lipido y una fase de solvente polar que no es agua, con un primer y segundo reactivo que tiene un grupo carbonilo libre y grupo amino disponible.
BR112015025523A2 (pt) preparação de lactilatos diretamente do óleo
BR112015021813A2 (pt) éster de isononila na base de misturas de ácidos graxos de óleos vegetais
BR112018016394A2 (pt) dispositivo e processo para isolar de ácidos nucleicos de sangue total
BR112013001942A2 (pt) ester de ácidos carboxílicos hidróxi o-substituído, processo para produzir pelo menos um éster de ácidos hidróxi carboxílicos o-substituídos, e, composição cosmética
BR112018017128A2 (pt) métodos para produzir um látex de polímero, uma composição de látex, um artigo moldado por imersão e um substrato de formação de camada de adesivo.
ES2571043T3 (es) Preparación de dihidropiridinas
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
AR107419A1 (es) Proceso para la preparación de ácidos 4-alcoxi-3-acetoxipicolínicos
BR112016025378A2 (pt) ?solução de haleto de magnésio, seu método de preparação e uso?
BR112017006616A2 (pt) Solução aquosa de 2-dimetilamino-2-hidroximetil-1,3 -propanodiol úteis para a remoção de gás ácido de misturas gasosas

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: ARDENIA INVESTMENTS, LTD (GB)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 870200003484 DE 08/01/2020, E NECESSARIO QUE O DOCUMENTO QUE COMPROVA TAL TRANSFERENCIA ESTEJA COM A DEVIDA LEGALIZACAO CONSULAR OU ACOMPANHADO DA APOSTILA DE HAIA.

B25A Requested transfer of rights approved

Owner name: OASMIA PHARMACEUTICAL AB (SE)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/12/2016, OBSERVADAS AS CONDICOES LEGAIS